| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |